Keykavous Parang

Title: Keykavous Parang: Innovator in Protein Kinase Inhibitors

Introduction

Keykavous Parang is a notable inventor based in Narragansett, Rhode Island, known for his contributions to the field of biochemistry. His work primarily focuses on the development of protein kinase inhibitors, which have significant applications in cancer therapy and cell signaling.

Latest Patents

Keykavous Parang holds 1 patent for his invention titled "Bisbubstrate inhibitors of kinases." This patent describes potent and selective bisubstrate inhibitors for the insulin receptor tyrosine kinase. These inhibitors are based on a phosphoryl transfer mechanism that involves a dissociative transition state. One of the synthesized inhibitors links ATPγS to a peptide substrate analog via a two-carbon spacer. This compound acts as a high-affinity competitive inhibitor against both nucleotide and peptide substrates, demonstrating a slow off-rate. A crystal structure of this inhibitor bound to the tyrosine kinase domain of the insulin receptor confirms the design features inspired by the dissociative transition state and reveals that the linker participates in the octahedral coordination of an active site magnesium ion.

Career Highlights

Throughout his career, Keykavous Parang has worked with prestigious institutions, including the Icahn School of Medicine at Mount Sinai and Johns Hopkins University. His research has significantly advanced the understanding of kinase inhibitors and their therapeutic potential.

Collaborations

Keykavous Parang has collaborated with esteemed colleagues such as Philip A. Cole and Ararat Abloogu, contributing to the advancement of knowledge in the field of protein kinases.

Conclusion

Keykavous Parang's innovative work in the development of protein kinase inhibitors showcases his commitment to advancing cancer therapeutics. His contributions continue to impact the scientific community and hold promise for future medical applications.